Themes Deliberate Release

Advice following the European consultation on the authorisation process of GMOs in medical applications

20.08.2021

CGM/210820-01

Advisory reports
Generic environmental risk assessment of clinical trials with MVA vectors

24.03.2021

CGM/210324-01

Advisory reports
Generic environmental risk assessment of replication-deficient adenoviral vectors in clinical trials

24.03.2021

210324-02

Advisory reports
Plant material inactivation

11.12.2020

CGM 2020-05

Advisory reports
No rose without thorns

10.10.2019

CGM/191010-01

Policy reports
Testing impacts of toxic compounds from transgenic crops on non-target arthropods in tier-1 studies: exposure and response

17.12.2015

CGM 2015-08

Research reports
Research report Survey of Field trials with Genetically Modified Plants – Global trends and developments

10.11.2014

CGM 2014-04

Research reports
Abstract of COGEM advisory reports on the application for a clinical trial testing recombinant Vaccinia virus- en Fowlpox virus- vaccine in patients with prostate cancer

26.09.2013

CGM/130926-01

Advisory reports
Criteria for the molecular characterisation of GMOs for medical and veterinary applications

27.02.2013

CGM/130227-05

Advisory reports
The use of statistical tools in field testing for effects of GM plants on non-target organisms (NTOs)

27.11.2012

CGM 2012-06

Research reports
Gene therapy clinical trials: what about the environment? A comparison between the Netherlands and North America

30.10.2012

CGM 2012-07

Research reports
The possible role of honeybees in the spread of pollen from field trials

14.05.2012

CGM 2012-02

Research reports